Since we practice evidence-based medicine that follows the available current research, we have looked at what research is available for this compound that explains its mechanism of action and/or evaluates its efficacy in the treatment of soft tissue injuries
Our products are not intended to diagnose, treat, cure, or prevent any disease.
Any dosing figures below describe clinical-trial protocols or, for cagrilintide, research conventions with no approved label not a personal protocol
Endogenous deficiency of glutathione as the most likely cause of serious manifestations and death in COVID-19 patients
BPC-157 promotes tendon healing at the cellular level by activating fibroblast migration, proliferating tenocyte populations, and upregulating growth factor receptor expression at the injury site
After sessions two and three, the structural improvement deepens